How Payers Are Driving the Site-of-Care Shift

Posted by Prateek Harsh on November 11, 2019

With all of the recent news from payers, 2019 is the year that the floodgates opened for ambulatory surgery centers (ASCs). This belief of mine was reinforced when I attended the 2019 Becker's ASC Annual Meeting, which took place Oct. 24-26 in Chicago. Payers, commercial or government, know that ASCs are about half of the cost of a hospital and have amassed increasing evidence of equal if not better outcomes than the hospital itself for the appropriate patient pool. These groups are now making big moves to realize significant cost savings from shifting the site of care.


>
Read More

Medtech’s Business Problems Need Marketing Solutions

Posted by Matt Singer on June 5, 2019

Sundeep Karnik co-wrote this blog post with Matt Singer. This is an excerpt from “Medtech, Look to Marketing for the Solution.”

We don’t need to tell you that the healthcare landscape is growing more complex and competitive, and that achieving growth is becoming more challenging for medtech organizations. We don’t need to mention that bringing true innovation to market—innovation that customers will pay for—isn’t as easy as it used to be or that many new product launches fail to deliver on expectations. We’ve sat in the offices of many industry leaders and discussed these very challenges.


>
Read More

Four Strategies That Medtech Companies Have Used to Monetize Digital Health

Posted by Matt Scheitlin on May 23, 2019

I recently had the privilege of participating in a digital health panel at The MedTech Forum in Paris. The title of the panel was “New Business Models for Digital Health: A Look at Value,” and I was joined by two industry colleagues—Agnes Simon, senior business director, EMEA, at Medtronic, and Lucile Blaise vice president of Western Europe at ResMed—to share our thoughts on business models for digital health in medtech. The conversation was wide-ranging and included tangible strategies for how the industry is currently trying to monetize its digital health innovation. Here are four:


>
Read More

Value-Based Healthcare Is So 2015. Now Products Are the Talk of Medtech

Posted by Brian Chapman on March 20, 2019

For as long as I can remember, value-based healthcare has been the talk of the medtech industry, and for good reason: Who can argue with efforts to improve patient outcomes at a lower cost? With such virtuous and unassailable aims, it’s the irresistible force that dominated strategies in the last decade.


>
Read More

Into 2019: Risk, Uncertainty and a Return to Product Focus

Posted by Brian Chapman on January 23, 2019

Looking ahead to what the medtech industry can expect in 2019, I see a continuation of some of the greatest accomplishments of 2018, such as ongoing collaboration with regulatory bodies and real-world evidence driving more reimbursement discussions, as well as the brave new world of digital health continuing to buoy how our industry can help patients.


>
Read More